Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Radiology · Vestibular Schwannoma

How Can I Manage Scanxiety During Schwannoma Surveillance?

At a Glance

Scanxiety during vestibular schwannoma active surveillance is common and can be eased with a clear MRI-and-results plan, reliable support, daily routines, and professional help when anxiety affects sleep or daily life. New or worsening symptoms still need prompt medical attention.

Living with a benign (noncancerous) tumor like a vestibular schwannoma (acoustic neuroma) under an “active surveillance” protocol can be incredibly stressful. Active surveillance is not simply “doing nothing”; it is a monitored management plan involving scheduled MRI scans and clinical follow-ups designed to safely track your condition over time. The psychological toll of knowing you have a tumor, combined with the anxiety leading up to and waiting for MRI results—often called “scanxiety”—is a recognized clinical issue.

It is common for anxiety to be highest around the time of your initial diagnosis [1]. Many people report that this distress lessens and quality of life stabilizes over time as they adjust to the observation period, though individual experiences vary [2][3]. While anxiety can amplify feelings of fatigue, dizziness, or balance problems [4][5], you should never automatically attribute new physical changes to stress. Contact your care team promptly if you experience new or worsening hearing loss, tinnitus, vertigo, facial numbness or weakness, or swallowing problems between scheduled scans.

Evidence-Based Coping Strategies

When you are in a surveillance period, it can feel like you have no control. However, there are actionable ways to cope with illness uncertainty and the stress of routine scans.

  • Limit unguided internet research: The internet can be a source of significant anxiety. Studies show that a large portion of online content regarding vestibular schwannomas (such as YouTube videos) is of poor or highly variable quality [6][7]. Check the source and date of medical information, and try to limit “doomscrolling.”
  • Connect with patient support groups: Engaging with structured patient organizations provides education and peer support [8][1]. The Acoustic Neuroma Association (ANA) is a broad resource for patients, while the Children’s Tumor Foundation provides specific support for those with NF2-related schwannomatosis. Keep in mind that reading other patients’ difficult stories can sometimes increase anxiety, so it is reasonable to step back if needed.
  • Maintain your daily routines: Engaging in your normal daily activities provides a sense of normalcy and helps manage the fear of tumor growth.
  • Seek professional support: If worry, low mood, or fear of tumor growth disrupts your sleep or daily life, consider professional psychological support. Studies in broader oncology and chronic-illness populations suggest that therapies like Cognitive Behavioral Therapy (CBT) and mindfulness may help reduce illness uncertainty and improve coping skills [9][10].

Managing Scan Day and Results

A major trigger for scanxiety is the actual MRI experience and the waiting period for results [11][12]. Knowing how your care team manages your surveillance can help ease this burden.

  • Prepare for the MRI: MRIs are noisy, confined, and long. Ask the imaging center in advance if you can listen to music or take breaks. If you experience severe claustrophobia, discuss anti-anxiety medication options with your doctor well before scan day (this will require having someone else drive you) [13].
  • Understand standardized imaging: Doctors use standardized MRI protocols for active surveillance to ensure consistent imaging [14][15]. This allows your team to accurately compare scans over time. Remember that small measurement differences can occur, and your clinician will interpret the scan alongside your specific symptoms.
  • Plan your results timeline: Some patients prefer reading reports as soon as they are available on a patient portal. However, radiology language is highly technical and can highlight uncertain findings. Studies suggest that having a structured, clinician-led discussion can help manage distress better than navigating uncertain results alone [16][12]. Agree with your doctor in advance on exactly how and when you will receive your results [17].
  • Know how decisions are made: Transitioning from surveillance to treatment is rarely based on a single “growth cutoff” number. Your team will integrate tumor growth rate, changes in hearing or balance, your age, and overall health into any decision about treatment.

Common questions in this guide

What is scanxiety during vestibular schwannoma surveillance?
Scanxiety is the worry or distress linked to MRI scans and waiting for results. It is common during active surveillance, especially near diagnosis or scan appointments, and may become easier to manage over time. Anxiety should not be used to explain away new physical symptoms.
How can I prepare for an MRI if I feel anxious or claustrophobic?
Ask the imaging center ahead of time whether you can listen to music or take breaks. If claustrophobia is severe, discuss medication with your doctor well before the appointment, and arrange for someone else to drive if medication is used.
Should I read my vestibular schwannoma MRI report as soon as it appears?
You can discuss with your care team whether you prefer immediate portal access or a planned conversation about the results. Radiology reports use technical language and may describe uncertain findings, so a clinician-led review can make the results easier to understand and less distressing.
What symptoms should I report between surveillance scans?
Contact your care team promptly about new or worsening hearing loss, tinnitus, vertigo, balance problems, facial numbness or weakness, or swallowing problems. Do not assume these changes are caused only by anxiety.
When should I get professional help for scanxiety?
Consider speaking with a clinical health psychologist or counselor if worry, low mood, or fear of tumor growth disrupts sleep or daily activities. Cognitive behavioral therapy and mindfulness may help some people cope with medical uncertainty.
What might lead doctors to change active surveillance?
A change in care is rarely based on one tumor-growth number alone. Clinicians consider the growth rate, hearing or balance changes, age, and overall health when discussing whether treatment should be considered.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific plan and timeline for how we will review my MRI results together?
  2. 2.What combination of tumor growth, symptom changes, or hearing loss would prompt a discussion about changing my care plan?
  3. 3.Can you recommend a clinical health psychologist or counselor trained in medical uncertainty?
  4. 4.What specific symptoms or changes in my balance, hearing, or facial sensation warrant a prompt call to the clinic between routine scans?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Quality of Life Within the First 6 Months of Vestibular Schwannoma Diagnosis With Implications for Patient Counseling.

    Carlson ML, Tombers NM, Kerezoudis P, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2018; (39(10)):e1129-e1136 doi:10.1097/MAO.0000000000001999.

    PMID: 30239440
  2. 2

    Prospective Study of Disease-Specific Quality-of-Life in Sporadic Vestibular Schwannoma Comparing Observation, Radiosurgery, and Microsurgery.

    Carlson ML, Barnes JH, Nassiri A, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2021; (42(2)):e199-e208 doi:10.1097/MAO.0000000000002863.

    PMID: 33177408
  3. 3

    Long-Term Prospective Quality-of-Life Outcomes in 445 Patients with Sporadic Vestibular Schwannoma.

    Carlson ML, Babajanian EE, Lohse CM, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2024; (45(10)):1167-1171 doi:10.1097/MAO.0000000000004328.

    PMID: 39439048
  4. 4

    What determines quality of life in patients with vestibular schwannoma?

    Pruijn IMJ, Kievit W, Hentschel MA, et al.

    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2021; (46(2)):412-420 doi:10.1111/coa.13691.

    PMID: 33326685
  5. 5

    Fatigue in patients with vestibular schwannoma.

    Dhayalan D, Lund-Johansen M, Finnkirk M, Tveiten ØV

    Acta neurochirurgica 2019; (161(9)):1809-1816 doi:10.1007/s00701-019-04003-2.

    PMID: 31321539
  6. 6

    The reliability and quality of online patient education videos for vestibular schwannoma.

    Giordano M, Caccavella VM, Tariciotti L, et al.

    British journal of neurosurgery 2024; (38(4)):811-816 doi:10.1080/02688697.2021.1973369.

    PMID: 34472385
  7. 7

    Assessing Readability and Reliability of Online Patient Information Regarding Vestibular Schwannoma.

    Spiers H, Amin N, Lakhani R, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2017; (38(10)):e470-e475 doi:10.1097/MAO.0000000000001565.

    PMID: 28885483
  8. 8

    Disease-Specific Quality of Life in Vestibular Schwannoma: A National Cross-sectional Study Comparing Microsurgery, Radiosurgery, and Observation.

    Chweya CM, Tombers NM, Lohse CM, et al.

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2021; (164(3)):639-644 doi:10.1177/0194599820941012.

    PMID: 32689889
  9. 9

    Effect of Psychological Intervention on Fear of Cancer Recurrence: A Systematic Review and Meta-Analysis.

    Tauber NM, O'Toole MS, Dinkel A, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019; (37(31)):2899-2915 doi:10.1200/JCO.19.00572.

    PMID: 31532725
  10. 10

    Interventions to Reduce Fear of Cancer Recurrence Among People With Cancer: Scoping Review.

    Li N, Wensley C, Reynolds L, et al.

    JMIR cancer 2026; (12()):e81579 doi:10.2196/81579.

    PMID: 42018993
  11. 11

    Surveillance-Associated Anxiety After Curative-Intent Cancer Surgery: A Systematic Review.

    Khatri R, Quinn PL, Wells-Di Gregorio S, et al.

    Annals of surgical oncology 2025; (32(1)):47-62 doi:10.1245/s10434-024-16287-5.

    PMID: 39343818
  12. 12

    Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.

    Shah MS, Memon JA, Malik U, et al.

    Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.

    PMID: 41077027
  13. 13

    Biomarkers and Psychological Factors Associated with Distress in Children, Adolescents, and Young Adults Undergoing MRI Neuroimaging: A Systematic Review of Observational Studies with Clinical Recommendations.

    Ceniza-Bordallo G, Del Pino AB, Soldic D, Torrado-Carvajal A

    Healthcare (Basel, Switzerland) 2026; (14(9)) doi:10.3390/healthcare14091160.

    PMID: 42121603
  14. 14

    An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies.

    Saslow L, Li DKB, Halper J, et al.

    International journal of MS care 2020; (22(5)):226-232 doi:10.7224/1537-2073.2020-094.

    PMID: 33177959
  15. 15

    New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.

    Brisset JC, Kremer S, Hannoun S, et al.

    Journal of neuroradiology = Journal de neuroradiologie 2020; (47(4)):250-258 doi:10.1016/j.neurad.2020.01.083.

    PMID: 32014494
  16. 16

    Alone with the diagnosis: A reflective analysis on imaging report access and emotional burden.

    Chau M

    Radiography (London, England : 1995) 2025; (31 Suppl 2()):103104 doi:10.1016/j.radi.2025.103104.

    PMID: 40764216
  17. 17

    Women's experiences and preferences regarding breast imaging after completing breast cancer treatment.

    Brandzel S, Rosenberg DE, Johnson D, et al.

    Patient preference and adherence 2017; (11()):199-204 doi:10.2147/PPA.S122244.

    PMID: 28203064

This page is for informational purposes only and does not constitute medical advice. It discusses coping with scanxiety during vestibular schwannoma surveillance; contact your care team about new symptoms, severe anxiety, or medication options.

Get notified when new evidence is published on Benign schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.